Cargando…

Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma

Prognostic tools are an essential component of the clinical management of patients with renal cell carcinoma (RCC). Although tumour stage and grade can provide important information, they fail to consider patient‐ and tumour‐specific biology. In this study, we set out to find a novel molecular marke...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Alwis, Roger, Schoch, Sarah, Islam, Mazharul, Möller, Christina, Ljungberg, Börje, Axelson, Håkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240150/ https://www.ncbi.nlm.nih.gov/pubmed/36947439 http://dx.doi.org/10.1002/cjp2.316

Ejemplares similares

Size-based isolation and detection of renal carcinoma cells from whole blood
por: De Alwis, Roger, et al.
Publicado: (2022)

Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
por: Gustafsson, Anna, et al.
Publicado: (2009)

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
por: Thomasson, Marcus, et al.
Publicado: (2012)

The Notch and TGF-β Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell Carcinoma
por: Sjölund, Jonas, et al.
Publicado: (2011)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
por: Fritz, Helena K., et al.
Publicado: (2015)

NFIA haploinsufficiency: case series and literature review
por: Dini, Gianluca, et al.
Publicado: (2023)

Combined allelic dosage of Nfia and Nfib regulates cortical development
por: Bunt, Jens, et al.
Publicado: (2017)

Truncating mutation in NFIA causes brain malformation and urinary tract defects
por: Negishi, Yutaka, et al.
Publicado: (2015)

Phenotypic Spectrum of NFIA Haploinsufficiency: Two Additional Cases and Review of the Literature
por: Bertini, Veronica, et al.
Publicado: (2022)

Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma
por: Sitaram, Raviprakash T., et al.
Publicado: (2016)

VHL status regulates transforming growth factor-β signaling pathways in renal cell carcinoma
por: Mallikarjuna, Pramod, et al.
Publicado: (2018)

Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma
por: Andersson-Evelönn, Emma, et al.
Publicado: (2020)

Specific Genomic Aberrations Predict Survival, But Low Mutation Rate in Cancer Hot Spots, in Clear Cell Renal Cell Carcinoma
por: Köhn, Linda, et al.
Publicado: (2015)

NFIA Haploinsufficiency Is Associated with a CNS Malformation Syndrome and Urinary Tract Defects
por: Lu, Weining, et al.
Publicado: (2007)

PAX6 does not regulate Nfia and Nfib expression during neocortical development
por: Bunt, Jens, et al.
Publicado: (2015)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Telomere Length in Relation to Immunological Parameters in Patients with Renal Cell Carcinoma
por: Svenson, Ulrika, et al.
Publicado: (2013)

Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in Sweden
por: Thorstenson, Andreas, et al.
Publicado: (2015)

Cell-specific NFIA upregulation promotes epileptogenesis by TRPV4-mediated astrocyte reactivity
por: Kong, Shuo, et al.
Publicado: (2023)

Gene Expression Profiling Predicts Survival in Conventional Renal Cell Carcinoma
por: Zhao, Hongjuan, et al.
Publicado: (2006)

Single Nucleotide Polymorphisms in the Wilms’ Tumour Gene 1 in Clear Cell Renal Cell Carcinoma
por: Li, Xingru, et al.
Publicado: (2013)

Identification and characterization of the long non-coding RNA NFIA-AS2 as a novel locus for body mass index in American Indians
por: Bandesh, Khushdeep, et al.
Publicado: (2023)

A psychometric evaluation of the Functional assessment of cancer therapy—kidney symptom index (FKSI-19) among renal cell carcinoma patients suggesting an alternative two-factor structure
por: Rosenblad, Andreas Karlsson, et al.
Publicado: (2021)

Nfia deletion in myeloid cells blocks expansion of myeloid-derived suppressor cells during sepsis
por: Dai, Jun, et al.
Publicado: (2017)

NFIA determines the cis-effect of genetic variation on Ucp1 expression in murine thermogenic adipocytes
por: Hiraike, Yuta, et al.
Publicado: (2022)

High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
por: Yusenko, Maria V, et al.
Publicado: (2009)

miR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1
por: LIU, CHANG, et al.
Publicado: (2015)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
por: Evelönn, Emma Andersson, et al.
Publicado: (2019)

Mutual Antagonism Between Sox10 and NFIA Regulates Diversification of Glial Lineages and Glioma Sub-Types
por: Glasgow, Stacey, et al.
Publicado: (2014)

Alteration of Gene Expression Signatures of Cortical Differentiation and Wound Response in Lethal Clear Cell Renal Cell Carcinomas
por: Zhao, Hongjuan, et al.
Publicado: (2009)

Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma
por: Mallikarjuna, Pramod, et al.
Publicado: (2019)

Metabolic Factors Associated with Risk of Renal Cell Carcinoma
por: Häggström, Christel, et al.
Publicado: (2013)

NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells
por: Tchieu, Jason, et al.
Publicado: (2019)

MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis
por: Zhu, Zhiguo, et al.
Publicado: (2020)

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study
por: Almdalal, Tarik, et al.
Publicado: (2022)

Correction: Metabolic Factors Associated with Risk of Renal Cell Carcinoma
por: Häggström, Christel, et al.
Publicado: (2013)

Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients
por: Steffens, Sandra, et al.
Publicado: (2012)

NFIA differentially controls adipogenic and myogenic gene program through distinct pathways to ensure brown and beige adipocyte differentiation
por: Hiraike, Yuta, et al.
Publicado: (2020)

The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53
por: Piqué-Borràs, Maria-Riera, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8tqedehvq420e24furfiagfog